Article Text

Download PDFPDF
Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia
  1. A Rasheed,
  2. J Simpson,
  3. E Rosenthal
  1. john.simpson{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Below are the ECGs of a newborn infant (39 weeks of gestational age) at three hours (left) and three days of life (right). Fetal supraventricular tachycardia was not controlled with maternal digoxin, but was …

View Full Text